Clovis Oncology
Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 20091 and is headquartered in Boulder, Colorado. The company is a publicly traded company on NASDAQ under the symbol CLVS and is in the NASDAQ Biotechnology Index with several products in its product pipeline.
As of December 31, 2017, the company was not profitable and had incurred losses in each year since its inception in April 2009. In December 2022, Clovis Oncology filed for Chapter 11 bankruptcy.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1241518213 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Clovis Oncology” date of foundation (×1) · confidence 0.95 revision URL